VENTRIPOINT DIAGNOSTICS LTD (VPT.CA) Stock Price & Overview
TSX-V:VPT • CA92281P2008
The current stock price of VPT.CA is 0.115 CAD. Today VPT.CA is down by 0%. In the past month the price decreased by -8%. In the past year, price decreased by -23.33%.
VPT.CA Key Statistics
- Market Cap
- 21.548M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.02
- Dividend Yield
- N/A
VPT.CA Stock Performance
VPT.CA Stock Chart
VPT.CA Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to VPT.CA. When comparing the yearly performance of all stocks, VPT.CA is a bad performer in the overall market: 83.96% of all stocks are doing better.
VPT.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to VPT.CA. VPT.CA has a bad profitability rating. Also its financial health evaluation is rather negative.
VPT.CA Earnings
VPT.CA Forecast & Estimates
VPT.CA Groups
Sector & Classification
VPT.CA Financial Highlights
Over the last trailing twelve months VPT.CA reported a non-GAAP Earnings per Share(EPS) of -0.02. The EPS increased by 23.15% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -1076.66% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
VPT.CA Ownership
VPT.CA Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| PRN | PROFOUND MEDICAL CORP | N/A | 256.57M | ||
| TLT | THERALASE TECHNOLOGIES INC | N/A | 68.121M | ||
| PINK | PERIMETER MEDICAL IMAGING AI | N/A | 61.626M | ||
| MIR | MEDMIRA INC | N/A | 45.499M | ||
| CNVI | CONAVI MEDICAL CORP | N/A | 43.436M | ||
| NSCI | NANALYSIS SCIENTIFIC CORP | N/A | 20.768M | ||
| ASG | AURORA SPINE CORP | N/A | 20.077M | ||
| MDX | MEDX HEALTH CORP | N/A | 16.397M | ||
| THRM | THERMA BRIGHT INC | N/A | 3.693M | ||
| VVTM | VVT MED INC | N/A |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the TSX Venture Exchange Exchange | Find stocks with similar TA and Setup ratings on the Canadian exchanges | Find stocks with similar Fundamental rating on the Canadian exchanges | Find the competitors with the best technical ratings on the Canadian exchanges | Find the competitors with the best fundamentals on the Canadian exchanges | Find the competitors with the best valuation on the Canadian exchanges | Find the competitors with the best dividend on the Canadian exchanges | Find the competitors with the best analyst ratings on the Canadian exchanges
About VPT.CA
Company Profile
VentriPoint Diagnostics Ltd. is a medical device company, which engages in the development and commercialization of diagnostic tools that monitor patients with heart disease. The company is headquartered in Toronto, Ontario. The company went IPO on 2005-11-09. The company is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. The company develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. The company provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. The company has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.
Company Info
IPO: 2005-11-09
VENTRIPOINT DIAGNOSTICS LTD
18 Hook Ave, Unit 101
TORONTO ONTARIO M2N 5Y7 CA
CEO: George Adams
Employees: 0
Phone: 14168484156
VENTRIPOINT DIAGNOSTICS LTD / VPT.CA FAQ
What does VENTRIPOINT DIAGNOSTICS LTD do?
VentriPoint Diagnostics Ltd. is a medical device company, which engages in the development and commercialization of diagnostic tools that monitor patients with heart disease. The company is headquartered in Toronto, Ontario. The company went IPO on 2005-11-09. The company is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. The company develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. The company provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. The company has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.
What is the stock price of VENTRIPOINT DIAGNOSTICS LTD today?
The current stock price of VPT.CA is 0.115 CAD.
Does VPT stock pay dividends?
VPT.CA does not pay a dividend.
What is the ChartMill technical and fundamental rating of VPT stock?
VPT.CA has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
Can you provide the PE ratio for VPT stock?
VENTRIPOINT DIAGNOSTICS LTD (VPT.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.02).